St. Vincent Cardiovascular Research Institute

St. Vincent Cardiovascular Research Institute (SVCRI) is a prominent clinical research organization based in Indianapolis, Indiana, and is a key component of the Ascension St. Vincent healthcare system. The institute specializes in the execution of Phase I through IV clinical trials, focusing on innovative treatments for structural heart disease, electrophysiology, and advanced heart failure. SVCRI is internationally recognized for its leadership in interventional cardiology, having served as a pivotal site for the development of transcatheter aortic valve replacement (TAVR) and other breakthrough medical devices. Through collaborations with major pharmaceutical and biotechnology sponsors, the institute facilitates patient access to novel therapies and remains at the forefront of cardiovascular clinical science.